시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
석면증 치료 시장 보고서(2025년)
Asbestosis Treatment Global Market Report 2025
상품코드 : 1760466
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,501,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,396,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,292,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

석면증 치료 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 예측 기간의 증가는 희귀 질환 연구에 대한 집중도 증가, 노인 인구 증가, 원격 의료 서비스 확대, 폐 연구에 대한 투자 증가, 표적 생물학적 제제의 출현에 기인할 수 있습니다. 예측 기간에 있어서의 주요 동향으로서는 인공지능을 탑재한 진단 툴, 웨어러블 호흡 모니터링 디바이스, 유전자 치료의 혁신, 나노 테크놀로지를 이용한 약물전달, 호흡기 케어에 있어서의 원격 의료의 이용, 항섬유화약의 개발 등을 들 수 있습니다.

석면증의 유병률 증가는 향후 수 년간 석면증 치료 시장의 확대를 견인할 것으로 예측됩니다. 산업 등 안전 규제가 불충분한 산업에서 일하는 노동자들이 석면에 장기간 직업적으로 노출되는 것에 기인하고 있습니다. 2024년 11월, 영국에 본사를 둔 정부 기관인 보건안전부는 2022년 493명이 석면증으로 사망했다고 보고했습니다.

호흡기 질환의 유병률 증가는 석면 치료 시장의 성장에 기여할 것으로 예측됩니다. 호흡기 질환은 폐, 코, 목, 기도와 같은 호흡기 시스템의 다른 부분에 영향을 미치는 광범위한 질병을 포함합니다. 이러한 질병의 발생이 증가하는 주요 원인은 대기 오염의 심각화이며, 기도에 자극을 주고 폐 기능을 악화시키는 유해한 오염 물질에 개인을 노출시키는 것입니다. 석면증 치료는 폐의 염증과 섬유화를 표적으로함으로써 호흡기 질환의 관리를 돕고, 질병의 진행을 늦추고 증상을 완화시킵니다. 이것은 약물 요법, 재활 및 지원 요법을 통해 삶의 질을 향상시키고 만성 질환 관리를 향상시킵니다. 예를 들어, 호주 통계국에 따르면 2023년 급성 호흡기 감염으로 인한 사망자 수는 361명으로 2022년 241명에서 크게 증가했습니다. 그 결과, 호흡기 질환의 유병률 증가가 석면증 치료 시장의 성장을 가속하는 주요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Asbestosis treatment refers to the medical care provided to individuals affected by asbestosis, a chronic lung disease caused by prolonged exposure to asbestos fibers. The treatment aims to improve the patient's quality of life by alleviating respiratory difficulties, reducing inflammation, and slowing the progression of the disease.

The primary treatment types for asbestosis include medications such as salbutamol, guaifenesin, acetaminophen, and prednisone, among others. Salbutamol, a bronchodilator, is commonly used to relieve symptoms of asthma and chronic obstructive pulmonary disease (COPD). Treatment options encompass medication, surgery, rehabilitation, and palliative care. Administration methods vary, including oral, inhalation, intravenous, and other routes. These treatments are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

The asbestosis treatment market research report is one of a series of new reports from The Business Research Company that provides asbestosis treatment market statistics, including asbestosis treatment industry global market size, regional shares, competitors with an asbestosis treatment market share, detailed asbestosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the asbestosis treatment industry. The asbestosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The asbestosis treatment market size has grown strongly in recent years. It will grow from $1.61 billion in 2024 to $1.75 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to growing industrialization, rising awareness of the risks associated with asbestos exposure, government health initiatives, increased healthcare spending, and extensive media coverage of asbestos-related diseases.

The asbestosis treatment market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to the increasing focus on rare disease research, a growing geriatric population, the expansion of telemedicine services, rising investments in pulmonary research, and the emergence of targeted biologics. Major trends in the forecast period include artificial intelligence-powered diagnostic tools, wearable respiratory monitoring devices, gene therapy innovations, nanotechnology-based drug delivery, the use of telemedicine for respiratory care, and the development of antifibrotic drugs.

The growing prevalence of asbestosis is expected to drive the expansion of the asbestosis treatment market in the coming years. Asbestosis is a chronic lung disease caused by prolonged exposure to asbestos fibers, leading to lung tissue damage and respiratory issues. The rising incidence of asbestosis is attributed to extended occupational exposure to asbestos, particularly among workers in industries such as construction, shipbuilding, and heavy manufacturing, where safety regulations may be insufficient. Asbestosis treatments help manage the disease by improving lung function and alleviating symptoms, thereby enhancing the quality of life for affected individuals. For example, in November 2024, the Health and Safety Executive, a UK-based government agency, reported 493 deaths from asbestosis in 2022, all among males. Consequently, the growing prevalence of asbestosis is driving the growth of the treatment market.

The increasing prevalence of respiratory diseases is expected to contribute to the growth of the asbestosis treatment market. Respiratory diseases encompass a wide range of conditions affecting the lungs and other parts of the respiratory system, including the nose, throat, and airways. The rising occurrence of these diseases is largely due to escalating air pollution, which exposes individuals to harmful pollutants that irritate the airways and worsen lung function. Asbestosis treatment aids in managing respiratory conditions by targeting lung inflammation and fibrosis, helping to slow disease progression and ease symptoms. This contributes to enhanced quality of life through medication, rehabilitation, and supportive care, improving chronic disease management. For instance, the Australian Bureau of Statistics reported 361 deaths from acute respiratory infections in 2023, a significant increase from 241 deaths in 2022. As a result, the increasing prevalence of respiratory diseases is a key factor driving the growth of the asbestosis treatment market.

In January 2025, ICV Partners, a US-based investment firm, announced its acquisition of Environmental Remedies LLC. This acquisition aims to accelerate the growth of ERI by expanding its geographic reach, improving operations, and pursuing strategic acquisitions, further solidifying its position as a leading provider of asbestos abatement and environmental remediation services in California. Environmental Remedies LLC specializes in asbestos abatement and environmental remediation, helping to prevent health risks such as asbestosis.

Major players in the asbestosis treatment market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck and Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Granules India Ltd., FibroGen Inc, Farmson Basic Drugs Pvt. Ltd., Atabay Pharmaceuticals and Fine Chemicals Inc., AMGIS Lifescience Ltd., Conscientia Industrial Co. Ltd., Sri Krishna Pharmaceuticals Ltd., Manus Aktteva Biopharma LLP, Thykn India International, Zhejiang Haizhou Pharmaceutical Co. Ltd., Inopha International Co. Limited, Synthokem Labs Pvt. Ltd.

North America was the largest region in the asbestosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in asbestosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the asbestosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The asbestosis treatment market consists of revenues earned by entities by providing services such as diagnostic evaluations, oxygen therapy, and long-term respiratory care aimed at alleviating symptoms and improving the quality of life for patients with asbestosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The asbestosis treatment market also includes sales of oxygen delivery systems, inhalers, nebulizers, and other respiratory support devices used to manage and treat asbestosis symptoms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Asbestosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on asbestosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for asbestosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The asbestosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Asbestosis Treatment Market Characteristics

3. Asbestosis Treatment Market Trends And Strategies

4. Asbestosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Asbestosis Treatment Growth Analysis And Strategic Analysis Framework

6. Asbestosis Treatment Market Segmentation

7. Asbestosis Treatment Market Regional And Country Analysis

8. Asia-Pacific Asbestosis Treatment Market

9. China Asbestosis Treatment Market

10. India Asbestosis Treatment Market

11. Japan Asbestosis Treatment Market

12. Australia Asbestosis Treatment Market

13. Indonesia Asbestosis Treatment Market

14. South Korea Asbestosis Treatment Market

15. Western Europe Asbestosis Treatment Market

16. UK Asbestosis Treatment Market

17. Germany Asbestosis Treatment Market

18. France Asbestosis Treatment Market

19. Italy Asbestosis Treatment Market

20. Spain Asbestosis Treatment Market

21. Eastern Europe Asbestosis Treatment Market

22. Russia Asbestosis Treatment Market

23. North America Asbestosis Treatment Market

24. USA Asbestosis Treatment Market

25. Canada Asbestosis Treatment Market

26. South America Asbestosis Treatment Market

27. Brazil Asbestosis Treatment Market

28. Middle East Asbestosis Treatment Market

29. Africa Asbestosis Treatment Market

30. Asbestosis Treatment Market Competitive Landscape And Company Profiles

31. Asbestosis Treatment Market Other Major And Innovative Companies

32. Global Asbestosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Asbestosis Treatment Market

34. Recent Developments In The Asbestosis Treatment Market

35. Asbestosis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기